Experts are worried that a drug, which improves speech in
Alzheimer's patients, may trigger false hopes. The popular rheumatoid arthritis
drug had shown significant improvement in patients with Alzheimer's in a study
appearing in the journal BioMed Central BMC Neurology.
The study involved just 12 patients and hence the
Alzheimer's Association has expressed concern.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
"People with Alzheimer's and their families may place undue value on this new finding based on the dramatic language used in its description and the apparent immediate effect," the group said. "We need to see work in other laboratories by scientists without financial interest in the product."
Dr. Scott Turner,
incoming director of the Memory Disorders Program at Georgetown University
Medical Center said there must be double-blind, placebo-controlled, randomized
clinical trials before any judgment is passed.
Source: Medindia
RAS/L
Source: Medindia
RAS/L
Exercise may Not Help in Dementia
Exercising is a good answer for almost any disease. But, when it comes to dementia, a group of researchers say that, at the moment, physical activity is not the 'perfect' answer as
Advertisement
 Study: Immune-based Treatment may Restore Speech in Alzheimer'sA new study into the treatment of Alzheimer's disease reports improvement in language abilities using a novel immune-based approach. | Advertisement
|
Early Alzheimer's Diagnosis, Treatment Possible: Study
Canadian scientists have unearthed clear evidence that increases in the size of the ventricles, fluid-filled cavities in the brain, are directly linked with cognitive impairment and
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.